Sign in Subscribe

Charlie Morris

Charlie Morris

Deflation Shock

Deflation Shock

Given recent events in financial markets, this is an update to explain recent events. The market has had a deflation fright but without a major event such as a default. That means bond yields (black) and inflation expectations (red) have fallen. Their combined value (blue) has cooled from 7.9%

Behind the Curve

Behind the Curve

It’s been a busy week for the central banks and data releases. The Federal Reserve held rates steady while giving strong signals for cuts in September. The Bank of England cut by 0.25%, and the Bank of Japan hiked for the first time since 2007. With all this

BOLD and the VIX – Why BOLD Beats the Stockmarket

BOLD and the VIX – Why BOLD Beats the Stockmarket

ByteTree BOLD Index Monthly Rebalancing Report; Following rebalancing on 31st July 2024, the new target weights for the BOLD Index are 25.3% Bitcoin and 74.7% Gold. The Vinter ByteTree BOLD1 Index (BOLD) invests in Bitcoin and Gold. BOLD combines the world’s two most liquid alternative assets on

The Summer Lull

The Summer Lull

Trade in Whisky; Consumers are feeling the pinch, and with another bout of political uncertainty, parts of the stockmarket are starting to feel the pressure. Either that, or it’s just the summer, which is the weakest part of the year for stockmarkets. Yet this summer, the economic surprise indices

Bitcoin by Presidential Decree

Bitcoin by Presidential Decree

ByteFolio Issue 118; 💡This issue covers Akash Network (AKT), Internet Computer (ICP), Raydium (RAY), and Helium (HNT). Two weeks ago, the ByteFolio title was The Trump Bump following the assassination attempt, as there seemed to be a link. Prior to that, I never assumed that former President Trump had anything

Venture: European Speciality Pharma

Venture: European Speciality Pharma

Issue 35; Personalised Drugs The speciality pharmaceutical industry focuses on high-cost, complex care therapies for patients with challenging disease states. Medications range from oral to cutting-edge injectable and biologic products, which often carry high risks of side effects, and can be personalised to the patient’s needs. The drugs themselves

Trump Slump

Trump Slump

The US stockmarket had a rough week, which I would largely attribute to politics. With a 68% probability of a Trump victory two weeks ago, the market knew what it was getting and rallied. He was a stockmarket-friendly President, as it rose 83% between 2017 and 2021 when he sat